IJIR: Your Sexual Medicine Journal addresses sexual medicine for all sexes and genders as an interdisciplinary field. This includes work from basic science researchers, urologists, obstetricians and gynaecologists, endocrinologists, cardiologists, family practitioners, internists, neurologists, psychiatrists, psychologists, radiologists and other physical and mental health care professionals. It also includes work from gender and sexuality researchers, sex therapists, and others with scholarly expertise in human sexuality and sexual well-being.

Established in 1989, the highly respected journal publishes ground-breaking work, including the first research on Viagra (Sildenafil). As the field and research has advanced the journal has continued to strive to keep up and remain relevant. Part of this being ensuring it supports the Sustainable Development Goals, particularly those that fall under SDG 3: Good Health and Well-Being, set by the United Nations.

One of the sub-goals of SDG 3 is 3.7 Sexual and Reproductive Health, which focuses on sexual and reproductive health services, information and education, as well as the integration of sexual health into policy. There has been a huge shift globally in our sexuality and gender, and a greater understanding of the nuances within this and how we all must acknowledge that everyone is unique. IJIR strives to ensure that it is supporting these goals; not only through publishing high impact research on new techniques or surgeries or treatments, but also by delving into the psychological, mental health, hormonal and sexuality aspects of sexual and reproductive health, which are intrinsically linked.

In the Transgender Care collection the editors sought to shed light on an evolving area of sexual medicine by providing a wide overview on the hot topics related to transgender healthcare. In the last decade the interest of the scientific community towards transgender healthcare has dramatically increased, with both diagnostic and therapeutic paths under continuous evolution. Surgical techniques to achieve genital gender affirming surgery are sharply improving, along with new technological developments. This collection from IJIR gives a wide overview on the hot topics related to transgender healthcare.

Nearly a decade ago IJIR recognized that the sexual medicine field was still heavily male focused, however that meant there was a hug gap in knowledge and research being published and a huge proportion of the population not being properly represented, studied or treated correctly. SDG 3 aims to ensure healthy lives and promote well-being for all at all ages, and this is what IJIR aims to do to. In its scope it proudly states it is for “all sexes and genders” and it stands by this. IJIR publishes research that studies all sexes and genders, as there is no doubt that treatment, drugs and so on are not one size fits all. The right course of action can often be as unique as the person being treated.

There have been huge developments, but there is still a long way to go and IJIR hopes to continue to be at the forefront of this. The Transgender Care collection is just one example of this, but there is a myriad of diverse research, covering LGBTQ+, cancer treatment, rare sexual disorders and more, in the journal for you to explore.